Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: clinical phase 2 trial

RAPT Therapeutics Launches Phase 2b Trial for Anti-IgE Therapy for Food...

Nanoparticles Delivered to Mice Block Alpha-Gal Reactions

Aravax’s Phase 2 Study Now Enrolling Children with Peanut Allergy

Viaskin Milk Results Shows Potential for Treatment of Milk Allergy in...

Baked Milk Oral Immunotherapy Found to be Effective Treatment for Cow’s...

Promising Food Allergy Treatment from Aravax Receives $12 Million Investment

Anaphylm™, Aquestive’s Needleless Sublingual Epinephrine, Takes Another Step Forward

Aravax Doses First Patient in Phase 2 Peanut Allergy Clinical Trial

Peptide Shows Promise as an Allergen-Agnostic Treatment for Food Allergy

Novel Peanut Allergy Treatment Shown to be Safe, Effective, and Lasting

Your School On Our Map

Put Your School on the Map